Editorial Board
The Editorial Board of the journal is responsible for maintaining the quality and integrity of the journal's content. The board members are experts in their respective fields and play a crucial role in the peer review process, ensuring that all articles published meet the highest academic standards.
The Editorial Board is committed to upholding the principles of academic excellence, transparency, and ethical publishing practices. They work closely with authors, reviewers, and the editorial team to facilitate a smooth publication process.
Editor-in-Chief
Bekadja Mohamed Amine MD
Editor-in-ChiefDepartment: Department of Hematology and Cell Therapy
Affiliation: Hematology and Cell Therapy, University of Oran, Oran
Designation: Professor
Email: bekadja.mohamed@univ-oran1.dzCountry: Algeria
I have been a specialist in Hematology since 1982 and a Professor of Hematology since 1999. I headed the Hematology and Cell Therapy Department from 2004 to 2023. I developed the autologous and allogeneic stem cell transplantation units, and the use of unfrozen stem cells.
Editorial Members
Bidemi Emmanuel Ekundayo PhD
Editorial MemberAffiliation: Biochemistry, Bamidele Olumilua University of Science and Technology, Ikere-Ekiti
Department: Department of Biochemistry
Designation: Lecturer
Email: ekundayo.bidemi@bouesti.edu.ngCountry: Nigeria
Dr. Bidemi Emmanuel Ekundayo brings expertise in biochemistry, neurodegeneration, and pharmacological science to our editorial team. As a faculty member at Bamidele Olumilua University of Science and Technology, he has authored impactful work on Alzheimer’s disease mechanisms, neuroprotective roles of vitamins and plant compounds, and oxidative stress models in disease. With a solid publication track record—including both empirical studies and comprehensive reviews—and growing scholarly impact, he is well positioned to contribute thoughtfully to manuscript evaluation, thematic guidance, and the strategic direction of the journal.
Deepshi Thakral PhD
Editorial MemberAffiliation: Laboratory oncology Unit, All India Institute of Medical Sciences, New Delhi
Department: Department of oncology Unit
Designation: Scientist
Email: deepshithakral@aiims.eduCountry: India
I have been actively involved in Biomedical research for more than two decades with expertise in molecular biology, immunology, and oncology. My ongoing research is focused on understanding the role of tumor microenvironment with special focus on stem cells and immune status in influencing the phenotypic and functional heterogeneity in haematological malignancies. We are using single cell transcriptomics to obtain a better understanding of Acute Myeloid Leukemia (AML) pathogenesis and chemo-resistance, especially the role of leukemic stem cells that contribute to high rate of relapse in AML. In parallel, another research focus is on the potential use of minimally invasive plasma-derived circulating tumor DNA (ctDNA) as a biomarker for real-time disease monitoring in AML. This may facilitate better prognostic risk stratification, options for targeted therapy, MRD assessment and relapse prediction in AML. Moreover, the genotype guided risk classification of AML with concurrent evaluation of immune phenotype in AML patients using cell free nucleic acids (ctDNA and circulating cell free RNA) is being investigated as a novel approach for disease monitoring that may facilitate the design of preclinical and early clinical studies of immunotherapeutic combinations for precision medicine in AML.